Modern view on the problem of diagnostics of renal angiomioadenomatous tumor

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Angiomyoadenomatous tumor as a nosological entity is not included in the latest version of the International Histological Classification of Kidney Tumors (WHO, 2022) and is related to provisional entity. Currently, there is no consensus among researchers about the nosological affiliation of an angiomyoadenomatous tumor.

Aim. To comparatively analyze the histological, immunophenotypic, ultrastructural and molecular parameters of renal angiomyoadenomatous tumor and clear cell papillary renal cell tumor.

Materials and methods. The study was performed on surgical specimen from 5 and 10 patients with renal angiomyoadenomatous tumor and with clear cell papillary renal cell tumor, respectively. Immunohistochemical study was carried out on paraffin sections according to the standard protocol. Antibodies HMWCK, AE1/AE3, СК7, E-Cadherin, EMA, PAX8 and СА9 were chosen. To study tumor tissues on semi-thin and ultra-thin sections, an electron microscope Philips TECNAI 12 BioTwinD-265 was used. For in situ fluorescent diagnostic detection, defined centromere probes, LSI 13/21, LSI N25 /LSI ARSA, TelVysion telomeric probe and a two-color VHL/CEP3 probe were used.

Results. Angiomyoadenomatous tumor is characterized by a three-phase structure. In contrast to clear cell papillary renal cell tumor, angiomyoadenomatous tumors show complete membranous expression of CA9.

Conclusion. Our results allow to state that angiomyoadenomatous tumor and clear cell papillary renal cell tumor are different neoplasms.

Full Text

Restricted Access

About the authors

Y. I. Osmanov

Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Email: osmanovyouseef@yandex.ru
ORCID iD: 0000-0002-7269-4190

Ph.D., MD, professor of Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Russian Federation, Moscow

E. A. Kogan

Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Email: koganevg@gmail.com
ORCID iD: 0000-0002-1107-3753

MD, professor, Institute of Clinical Morphology and Digital Pathology of I.M. Sechenov First Moscow State Medical University

Russian Federation, Moscow

Z. K. Gadzhieva

FGAOU VO I.M. Sechenov First Moscow State Medical University

Email: zgadzhieva@ooorou.ru

Ph.D., MD, Head of the Department of analysis of personnel policy, educational programs and scientific research of the National Medical Research Center for «Urology», FGAOU VO I.M. Sechenov First Moscow State Medical University

Russian Federation, Moscow

S. G. Radenska-Lopovok

Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Email: radenska@mail.ru
ORCID iD: 0000-0002-4669-260X

Ph.D., MD, professor of Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Russian Federation, Moscow

D. D. Protsenko

Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Email: chief@medprint.ru
ORCID iD: 0000-0002-5851-2768

Ph.D., assistant professor of Institute of clinical morphology and digital pathology of FGAOU VO I.M. Sechenov First Moscow State Medical University

Russian Federation, Moscow

References

  1. Jayalakshmy P.S., Jose M., Feroze M. et al. Renal angiomyoadenomatous tumour. Turk J Urol. 2017;43(3):378–382. doi: 10.5152/tud.2017.32067.
  2. Jimenez R.E., Eble J.N., Reuter V.E. et al. Concurrent angiomyolipoma and renal cell neoplasia: A study of 36 cases. Mod Pathol. 2001;14:157–163. doi: 10.1038/modpathol.3880275.
  3. Michal M., Hes O., Nemcova J. et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454(1):89–99. doi: 10.1007/s00428-008-0697-3.
  4. Lobo J., Ohashi R., Amin M.B. et al. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 2022 May 21. Doi.org/10.1111/his.14700.
  5. Epstein J.I., Egevad L., Amin M.B. et al. Grading Committee. The 2014 International Society of Urological Pathology (ISUP) сonsensus сonference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244–252. Doi.org/10.1097/PAS.0000000000000530
  6. Wang L., Williamson S., Wang M. et al. Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy. J Molecular Cancer. 2014;13:39. doi.org/10.1186/1476-4598-13-39.
  7. Cossu-Rocca P., Eble J.N., Zhang S. et al. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. J Modern Pathology. 2006;19:780–787. doi.org/10.1038/modpathol.3800604
  8. Shi S.S., Shen Q., Xia Q.Y. et al. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. Int J Clin Exp Pathol. 2013;6(12):2936–2942. PMID: 24294381.
  9. Anik Sahni V., Hirsch M., Silverman S. Renal angiomyoadenomatous tumour: Imaging features. Can Urol Assoc J. 2012;6(4):E140–E143. doi: 10.5489/cuaj.11072.
  10. Williamson S.R., Hornick J.L., Eble J.N. et al. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex. Hum Pathol. 2018;75:10–15. doi: 10.1016/j.humpath.2017.11.013.
  11. Kuhn E., De Anda J., Manoni S. et al. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literature. Am J Surg Pathol. 2006;30(11):1372–1381.doi: 10.1097/01.pas.0000213277.45715.82.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig 1. Light-cell papillary tumor of the kidney. Tubulo-papillary structures. Hematoxylin and eosin staining. x40

Download (298KB)
3. Fig. 2. Angiomyoadenomatous tumor. Glandular and pseudopapillary structures in the leiomyomatous stroma. True papillae are absent. Hematoxylin and eosin staining. x40

Download (205KB)
4. Fig. 3. Light-cell papillary tumor of the kidney. Reversed polarity of the nuclei. Thin fibro-vascular rods in the true papillae are identified. Hematoxylin and eosin staining. x400

Download (160KB)
5. Fig. 4. Light-cell papillary renal cell tumor. Basolateral membrane decoration of tumor cells by CA9 expression. x400

Download (219KB)
6. Fig. 5. Light-cell papillary renal cell tumor. True desmosomes (D) and intercellular tight contacts (ICCs) are identified between tumor cells. A similar pattern is seen in tumor cells of angiomyoadenomatous tumor. x20,000

Download (135KB)
7. Fig. 6. Angiomyoadenomatous tumor. Microvilli (MV) are defined on the apical surface of the cell. Cisternae of granular endoplasmic reticulum (SER), glycogen grains (G) and a small number of lipid granules (LG) are seen in the cytoplasm. A similar pattern is seen in tumor cells of a luminal papillary renal cell tumor. x20,000

Download (207KB)

Copyright (c) 2024 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies